Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study. - Harris, John E; Papp, Kim; Ezzedine, Khaled; Sebastian, Michael; Pandya, Amit G; Seneschal, Julien; Amster, Mark; Alam, Maryam Shayesteh; Forman, Seth B; Zdybski, Jacek (British Journal of Dermatology, 2026)